Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Budget setbacks happen, but recovery is possible. Learn a practical plan to diagnose errors, restore discipline, and regain financial momentum.
11,251 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Is there a true housing shortage in the United States, or is the story driven by location, price, and policy? This ar...
A veteran wealth manager bets international exposure through a broad non-U.S. ETF to diversify risk and tap growth ou...
Eight trade groups push lower capital charges for mortgage servicing rights and advocate for tailored risk weights, a...
A Utah mother of three stands trial for murder after a year of tragedy, with prosecutors alleging a fentanyl-linked d...
A high-profile stage moment reshaped Jelly Roll's narrative, but off-camera leaks can quietly alter financial outcome...
This article analyzes Summit's Q4 2025 earnings context, what the numbers could imply for the summit (smmt) 2025 earn...
CECO (CECO) 2025 earnings will hinge on project backlogs, margins, and demand for air quality and energy solutions. T...
Two tech giants are racing to lead AI-enabled advertising, search, and social platforms. This article analyzes why Al...
SoundHound AI is testing a high-growth path in voice commerce and Vision AI. This article explains why some investors...
D-Wave QBTS delivered a notable Q4 2025 run, with rising revenue and expanding services. This story breaks down what ...
Apple is rumored to launch AI wearable devices in the coming years. This article explains how these smart devices cou...